Tag:
Catalent Pharma Solutions
Latest Headlines
Latest Headlines
Catalent deals target China from 2 directions
More and more companies are looking for the best way to capture a piece of the expanding Chinese market, and Catalent Pharma Solutions intends to be among them. It has nailed down two deals that will give it manufacturing capacity there.
Catalent expands Chinese presence with two joint ventures
Catalent Pharma Solutions is betting big on the Chinese market, launching two joint ventures for its Softgel Technologies and Clinical Supply Solutions businesses.
Catalent puts $20M into nasal drug delivery
Catalent Pharma Solutions is again expanding its manufacturing operations in North Carolina, this time to build new capacity for inhalation drugs.
Catalent cuts 45 at U.K. plant as demand 'changes'
Catalent Pharma Solutions says the demand for products at its plant in Swindon, U.K., is "changing," and so it is reducing head count there by nearly four dozen employees.
Catalent, Parexel team up for trial supply
Catalent Pharma Solutions and Parexel International have joined forces to streamline the supply chain for clinical trials, saying their combined expertise can cover clients from early-stage planning to post-trial disposal.
Catalent targets South Korea with CTC Bio partnership
Catalent Pharma Solutions has teamed up with South Korea's CTC Bio to attract clients looking to market solid oral dose and controlled-release products in the U.S. and Europe.
Filling services help Dalton seal manufacturing deal with Clarity
The Toronto CMO has a manufacturing services agreement with Clarity Pharmaceuticals, providing cGMP chemistry manufacturing, scale up, aseptic fill and finish services and analytical support for the Australian radiopharmaceutical company.
Catalent completes work on NC fill-finish plant
The NC facility ties into Catalent's plan to boost its offerings in areas like advanced blow-fill-seal aseptic delivery, delivery technologies and clinical trial supplies, among others.
Catalent to sell its U.S. commercial packaging ops to VC group Frazier Healthcare
Global CMO Catalent Pharma Solutions will unload its U.S. commercial packaging operations and sell it to venture capital group Frazier Healthcare for an undisclosed fee, according to a Catalent release.
Download our eBook 'Supplying global clinical trials: Keys to avoiding costly delays'
Getting clinical trials right, and right the first time, is crucial for biopharma companies, especially as the cost of getting a drug to market is skyrocketing. Matthew Herper estimates in "The...
